Monte Rosa Therapeutics Price Target $25.00 by HC Wainwright
HC Wainwright & Co. initiated coverage of Monte Rosa Therapeutics with a price target of $25.00 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.